• Research To Practice | Oncology Videos

  • De: Dr Neil Love
  • Podcast
Research To Practice | Oncology Videos  Por  arte de portada

Research To Practice | Oncology Videos

De: Dr Neil Love
  • Resumen

  • Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
    Copyright © 2023 Research To Practice. All Rights Reserved.
    Más Menos
Episodios
  • Myelofibrosis | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Myelofibrosis
    Jun 6 2024

    Featuring perspectives from Ms Ilene Galinsky, Dr Andrew T Kuykendall, Dr Sara M Tinsley-Vance and Dr Abdulraheem Yacoub, including the following topics:

    • Introduction (0:00)
    • The Biology of Myelofibrosis (MF) (14:00)
    • Role of Available and Investigational JAK inhibitors for the Management of MF (45:49)
    • Promising Agents and Strategies for Patients with MF (1:23:17)

    NCPD information and select publications

    Más Menos
    1 h y 31 m
  • Ovarian Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Ovarian Cancer
    Jun 4 2024

    Featuring perspectives from Ms Courtney Arn, Dr Floor J Backes, Dr Kathleen N Moore and Ms Jaclyn Shaver, including the following topics:

    • Introduction: The Incidence, Pathogenesis and Prognosis of Ovarian Cancer (0:00)
    • Genetic Testing for Newly Diagnosed Advanced Ovarian Cancer (11:01)
    • The Role of PARP Inhibitor Maintenance for Newly Diagnosed Advanced Ovarian Cancer (19:02)
    • Side Effects Associated with PARP Inhibitors (29:58)
    • Dosing, Adherence and Other Issues with PARP Inhibitors for Ovarian Cancer (48:29)
    • The Potential Role of PARP Inhibitors in Combination with Anti-PD-1/PD-L1 Antibodies for Advanced Ovarian Cancer Management (54:11)
    • PARP Inhibitors for Relapsed/Refractory Ovarian Cancer (1:00:36)
    • The Current Role of Mirvetuximab Soravtansine for Ovarian Cancer Treatment (1:07:14)
    • Toxicities with Mirvetuximab Soravtansine (1:11:53)
    • The Incidence and Management of HER2-Positive Ovarian Cancer (1:18:18)

    NCPD information and select publications

    Más Menos
    1 h y 32 m
  • Head and Neck Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Head and Neck Cancer
    May 31 2024

    Featuring perspectives from Ms Meetal Dharia, Dr Robert L Ferris, Dr Robert Haddad and Ms Lynsey P Teulings, including the following topics:

    • Introduction (0:00)
    • The Biology of Head and Neck Cancer (15:41)
    • The Multidisciplinary Treatment of Head and Neck Cancer (18:14)
    • Ongoing Screening and Prevention After Potentially Curative Therapy for Head and Neck Cancer (33:03)
    • Radiation Therapy and Chemotherapy Side Effects (41:02)
    • The Potential Short- and Long-Term Effects of Surgery for Head and Neck Cancer (49:50)
    • Emerging Treatment Strategies Aimed at Improving Outcomes Associated with Localized or Locally Advanced Head and Neck Cancer (56:46)
    • Tolerability Considerations with Xevinapant (1:06:13)
    • The Established Role of Anti-PD-1/PD-L1 Antibodies in Therapy for Advanced Head and Neck Cancer (1:17:35)
    • Newly Approved Immunotherapeutic Strategies for Nasopharyngeal Carcinoma (1:19:27)
    • The Tolerability of Immune Checkpoint Inhibitors (1:24:09)

    NCPD information and select publications

    Más Menos
    1 h y 31 m

Lo que los oyentes dicen sobre Research To Practice | Oncology Videos

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.